Pathogenic cysteine mutations affect progranulin function and production of mature granulins
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2010) 112, 1305–1315. Frontotemporal dementia with ubiquitin‐positive inclusions (FTLD‐U) can be caused by mutations in the progranulin gene (GRN). Progranulin (PGRN) is a cysteine‐rich growth factor, which is proteolytically cleaved by elastase to produce several granulins (GRNs). All FTLD‐U mutations in GRN characterized to date result in reduced secreted PGRN protein. We recently reported a Spanish family with progressive non‐fluent aphasia and dementia in which a novel C521Y mutation segregates with disease. A second cysteine mutation (C139R) has also been reported to be disease specific. Allele‐specific mRNA expression assays in brain reveal that the C521Y mutant allele is expressed at similar levels to the wild‐type allele. Furthermore, plasma PGRN levels in C521Y carriers are comparable with non‐carrier family relatives, suggesting that the mutation does not affect PGRN protein expression and secretion in vivo. Despite normal PGRN levels C521Y and C139R mutant GRN s show reduced neurite growth‐stimulating activity in vitro. Further study revealed that these mutations also cause impaired cleavage of PGRN by elastase. Our data suggest that these mutations affect the function of full‐length PGRN as well as elastase cleavage of PGRN into GRNs, leading to neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 2×
“Most of the mutations introduce premature termination codons into the mutant allele resulting in null alleles that show decreased mRNA stability suggesting a non-sense-mediated decay mechanism with no mutant protein translated (Baker et al. 2006; Cruts et al. 2006).”
BackgroundMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · cited 2×
“be/FTDMutations/) and show abnormal tau pathology in the brain (Hutton et al. 1998; Poorkaj et al. 1998; Spillantini et al. 1998).”
BackgroundProgranulin: normal function and role in neurodegeneration
Eriksen, J. L., & Mackenzie, I. R. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04968.x · Cited by 144
Cited by
Progranulin, lysosomal regulation and neurodegenerative disease
Kao, A. W., McKay, A., Singh, P. P., Brunet, A., & Huang, E. J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.36 · Cited by 258
The lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230
Genetics of FTLD : overview and what else we can expect from genetic studies
Pottier, C., Ravenscroft, T. A., Sanchez‐Contreras, M., & Rademakers, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13622 · Cited by 148
Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease
Chitramuthu, B. P., Bennett, H. P. J., & Bateman, A. (2017) · Brain · doi:10.1093/brain/awx198 · Cited by 138
“Missense mutations, C139R (Brouwers et al., 2008; Bernardi et al., 2009; Wang et al., 2010a; Antonell et al., 2012; Gass et al., 2012), in the F domain and C521Y (Wang et al., 2010a) in the E granulin domain do not alter progranulin secretion (Brouwers et al., 2008) or do so to a lesser degree than…”
BackgroundInfluential
Metadata
- Authors
- Wang, J., Van Damme, P., Cruchaga, C., Gitcho, M. A., Vidal, J. M., Seijo‐Martínez, M., Wang, L., Wu, J. Y., Robberecht, W., & Goate, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-02-02
- Volume
- 112
- Issue
- 5
- Pages
- 1305-1315
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1967056975
- Cited by
- 82
- References
- 6
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenic cysteine mutations affect progranulin function and production of mature granulins. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06546.x
- The paper
- Wang, J., Van Damme, P., Cruchaga, C., Gitcho, M. A., Vidal, J. M., Seijo‐Martínez, M., Wang, L., Wu, J. Y., Robberecht, W., & Goate, A. (2010). Pathogenic cysteine mutations affect progranulin function and production of mature granulins. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06546.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.